...that when IBM conducted a market study of Chester Carlson's invention in 1959, the company concluded that it would take only 5000 units of his new product to saturate the market? IBM therefore declined to be part of the new product introduction. Too bad for IBM. Carlson's invention was the xerography process, and his new product was the beginning of the Xerox Corporation. It is estimated that every day, worldwide, 3,000,000,000 copies are made!!
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7256200 | Method and composition for potentiating an oplate analgesic Composition and methods of treating pain and reducing, reversing, or preventing tolerance to opiate analgesics are disclosed. The composition and method utilize an opiate analgesic and a calcium calmodulin kinase (CaMKII) inhibitor as active agents to treat pain in ... | 08/14/2007 |
| 7208175 | Process for the production of rapidly disintegrating, solid pharmaceutical preparations Rapidly disintegrating preparations containing at least one active pharmaceutical ingredient and at least one excipient can be obtained by a simple process in which at least the predominant part of the complete composition of the ingredients for the preparation to b... | 04/24/2007 |
| 7060718 | Arylsulfonanilide ureas The invention provides compounds, compositions and methods relating to novel arylsulfonanilide derivatives and their use as pharmacologically active agents. The compositions find particular use as pharmacological agents in the treatment of disease states, particular... | 06/13/2006 |
| 7030103 | Sulfonamidomethyl phosphonate inhibitors of β-lactamase The intention relates to bacterial antibiotic resistance and, in particular, to compositions and methods for overcoming bacterial antibiotic resistance. The invention provides novel β-lactamase inhibitors, which are structurally unrelated to the natural product and... | 04/18/2006 |
| 6949521 | Therapeutic azide compounds Pharmaceutical prodrug compositions are provided comprising azide derivatives of drugs which are capable of being converted to the drug in vivo. Azide derivatives of drugs having amine, ketone and hydroxy substituents are converted in vivo to the corresponding drugs... | 09/27/2005 |
| 6921756 | Inhibitors of β-lactamase The invention relates to bacterial antibiotic resistance and, in particular, to compositions and methods for overcoming bacterial antibiotic resistance. The invention provides novel β-lactamase inhibitors, which are structurally unrelated to the natural product and... | 07/26/2005 |
| 6884791 | Inhibitors of β-lactamase The intention relates to bacterial antibiotic resistance and, in particular, to compositions and methods for overcoming bacterial antibiotic resistance. The invention provides novel β-lactamase inhibitors, which are structurally unrelated to the natural product and... | 04/26/2005 |
| 6822001 | Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents Combination therapies are provided for the treatment of proliferative disorders which use a pentafluorobenzenesulfonamide of formula I and an antineoplastic agent such as gemcitabine or paclitaxel. ... | 11/23/2004 |
| 6737068 | Wipe formulation The present invention relates to a liquid formulation for a feminine wipe. The preferred formulation has an anti-irritant agent, a pH adjuster namely citric acid, and at least one preservative. ... | 05/18/2004 |
| 6699902 | Acetyloxymethyl esters and methods for using the same Novel acetyloxymethyl esters are disclosed. Methods of treating an illness, including cancer, hemological disorders and inherited metabolic disorders, and treating or ameliorating other conditions using these compounds are also disclosed. The compounds ar... | 03/02/2004 |
| 6620800 | Methods and compositions to assess oxidative brain injury A method to assess oxidative stress in vivo includes the steps of measuring an amount of neuroprostanes in a biological sample before the ex vivo development of neuroprostanes in a sample, comparing the measured amount of neuroprostanes with a control and... | 09/16/2003 |
| 6355628 | Combination therapy using pentafluorobenzenesulfonamides Combination therapies are provided for the treatment of proliferative disorders which use a pentafluorobenzenesulfonamide of formula I and an antineoplastic platinum coordination complex such as cisplatin.... | 03/12/2002 |
| 6313106 | Phospholipid derivatives of valproic acid and mixtures thereof The present invention relates to compounds, which are phospholipid derivatives of valproic acid, to compositions comprising said compounds and their use for treating epilepsy, migraine, bipolar disorders and pain.... | 11/06/2001 |
| 6271212 | Prodrug azide compositions and compounds Pharmaceutical prodrug compositions are provided comprising azide derivatives of drugs which are capable of being converted to the drug in vivo. Azide derivatives of drugs having amine, ketone and hydroxy substituents are converted in vivo to the correspo... | 08/07/2001 |
| 6235727 | Sulfonylaminophosphinic and sulfonylaminophosphinic acid derivatives, methods for their preparation and use Compounds of the formula I ##STR1## are suitable for the production of pharmaceuticals for the prophylaxis and therapy of disorders in the course of which an increased activity of matrix-degrading enzymes is involved.... | 05/22/2001 |
| 6211167 | Arylsulfonanilide phosphates The invention provides compounds, compositions and methods relating to novel arylsulfonanilide derivatives and their use as pharmacologically active agents. The compositions find particular use as pharmacological agents in the treatment of disease states,... | 04/03/2001 |
| 6077837 | Prodrugs with enhanced penetration into cells The invention relates to a pharmaceutically acceptable prodrug which is a covalent conjugate of a pharmacologically active compound and an intracellular transporting adjuvant, characterized by the presence of a covalent bond which is scission-sensitive to... | 06/20/2000 |
| 6040338 | N,n-bis(sulfonyl)hydrazines useful as antineoplastic agents The present invention relates to a compound of the formula wherein R1 and R2 are selected from lower alkyl groups having 1-6 carbon atoms, substituted or unsubstituted aryl groups, and unsaturated alkyl groups having 1-6 carbon atoms... | 03/21/2000 |
| 5939455 | Therapeutic augmentation of oxyalkylene diesters and butyric acid derivatives This invention provides a method of augmenting the therapeutic activity of an oxyalkylene-containing compound, butyric acid, a butyric acid salt or butyric acid derivative by administering an inhibitor of ଲ-oxidation of fatty acids to a patient or t... | 08/17/1999 |
| 5576308 | Organophosphorus compounds and insecticides, acaricides and nematocides containing same An insecticidal, acaricidal or nematocidal composition which comprises an organophosphorus compound represented by formula (I): ##STR1## wherein R1, R2 and R3 each represents C1 to C4 alkyl; A re... | 11/19/1996 |
| 5527829 | HIV protease inhibitors HIV protease inhibitors, obtainable by chemical synthesis, inhibit or block the biological activity of the HIV protease enzyme, causing the replication of the HIV virus to terminate. These compounds, as well as pharmaceutical compositions that contain the... | 06/18/1996 |
| 5449662 | Atrial natriuretic peptide clearance inhibitors which resist degradation Compounds with natriuretic, diuretic and/or vasodilation activity which enhance the function of an endogenous ANP are provided. These compounds are capable of both binding to the clearance receptors for ANP and of inhibition of endopeptidase 24.11, an enz... | 09/12/1995 |
| 5354742 | Water-dispersible granules and process for the preparation thereof The invention is directed to a pesticide composition comprising free flowing, essentially spherical, water-dispersible granules wherein said water-dispersible granules are from about 150 to about 850 microns in diameter; wherein said granules contain up t... | 10/11/1994 |
| 5169433 | Method of preparing mixtures of active ingredients and excipients using liquid carbon dioxide Environmentally-acceptable intimate mixtures of active ingredients and excipients which meet economic performance levels are prepared without use of harmful solvents by solubilizing and mixing the components in liquid carbon dioxide maintained under press... | 12/08/1992 |
| 5124321 | 17-halomethylene estratrienes 17-halomethylene estratrienes of Formula I ##STR1## wherein R1 is hydrogen, a methyl or acyl group, and R2 is a halogen atom, show low affinity to the estrogen receptor and bring about a cellular membrane and blood/lymphatic vessel p... | 06/23/1992 |
| 5108991 | Vehicle composition containing 1-substituted azacycloalkan-2-ones Compositions useful for carrying physiologically active agents such as therapeutic agents through skin and other body membranes comprising the agent and an effective, non-toxic amount of a compound having the structural formula ##STR1## wherein ... | 04/28/1992 |
| 4999345 | Sulfonamide derivatives and drugs obtained therefrom Sulfonamide derivatives of the formula I ##STR1## where R1 is a C1 -C4 -alkyl or phenyl group which may be substituted by halogen, trifluoromethyl or C1 -C4 -alkyl, R2 is hydrogen or C... | 03/12/1991 |
| 4804654 | Certain N-(R-sulfonyl) phosphonamidothioates and dithioates Compounds of the formula ##STR1## wherein the symbols have assigned meanings, and their use as insecticides and/or miticides.... | 02/14/1989 |
| 4781920 | Anthelmintic paste compositions containing resinates of d1-6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole The invention provides physically stable anthelmintic paste compositions containing resinates of d1-6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole and other anthelmintic compounds in combination with a wide variety of therapeutic agents such as an... | 11/01/1988 |
| 4663364 | Biocidal fine powder, its manufacturing method and a suspension for agricultural use containing the above powder A biocidal powder having a notably reinforced biological effect contains at least 50 wt % of particles having diameter of 0.5 micron or less. A suspension containing the above powder is prepared by mixing a dispersion liquid which comprises a biocidal substanc... | 05/05/1987 |
| 4629491 | Oxidized sulfur derivatives of diaminophosphinyl compounds as urease inhibitors and urease inhibited urea based fertilizer compositions The invention relates to novel urease inhibited fertilizer compositions containing urea and a urease inhibiting amount of one or more diaminophosphinyl compounds having oxidized sulfur functions, and methods and composition for inhibiting the activity of ... | 12/16/1986 |
| 4411895 | Method for controlling bluetongue disease in sheep A method for the control of bluetongue disease amongst sheep by the application of O, O-dimethyl O-p-(dimethylsulfamoyl) phenyl phosphorothioate directly to the back of the animal. Such application of a chemotherapeutic dosage prevents contamination of th... | 10/25/1983 |
| 4405614 | N-Sulfonylated thiolphosphoric ester amides and their use for controlling pests N-sulfonylated thiolphosphoric ester amides of the formula ##STR1## where R1, R2, R3, X and n have the meanings given in the description, and their use for controlling insects, arachnida and nematodes.... | 09/20/1983 |
| 4368196 | Phosphoric acid esters, and their use for combating pests Novel phosphoric acid esters of the formula ##STR1## where R1 is alkoxy of a maximum of 4 carbon atoms or phenyl, R2 is alkyl of a maximum of 3 carbon atoms, alkoxy or alkylthio of a maximum of 4 carbon atoms, or alkylamino or d... | 01/11/1983 |
| 4212887 | N-Methyl-N-(sulphonic acid amide-n'-sulphenyl)-carbamic acid esters N-Methyl-N-(sulphonic acid amide-N'-sulphenyl)-carbamic acid esters of the formula ##STR1## in which R1 is dialkylamino with 1 to 4 carbon atoms in each alkyl radical, phenyl or phenyl carrying at least one halogen, alkyl with 1 to 4 ... | 07/15/1980 |
| 4203977 | Phosphoric acid esters, composition and use Phosphoric (phosphonic) acid esters of the formula ##STR1## where R1 denotes linear or branched alkyl of up to 4 carbon atoms, R2 denotes linear or branched alkyl, alkoxy or alkylthio, each of up to 4 carbon atoms, mono- or dial... | 05/20/1980 |
| 4176176 | Hair shampoo and cleanser compositions Hair shampoos and cleansers containing distinctly minor proportions of hydrophobic-lipophobic perfluorinated compounds.... | 11/27/1979 |
| 4122174 | Combating pests with O-alkyl-N-sulfamyl-phosphoramidothiolates O-Alkyl-N-sulfamyl-phosphoramidothiolates of the formula ##STR1## in which R1 is alkyl with 1-6 carbon atoms, R2 is alkyl or alkenyl with up to 6 carbon atoms, R3 is alkyl with 1-6 carbon atoms or aryl, R4 is alkyl w... | 10/24/1978 |
| 3934010 | Insecticidal composition and method utilizing phosphoric acid phenylsulphonamide esters Insecticidal and acaricidal compositions and methods for combating insects and acaricides are provided wherein the active insecticidal ingredients are phosphoric acid phenylsulphonamide esters of the formula ##SPC1## Wherein Y represents oxygen or sulphur... | 01/20/1976 |